![Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News](https://s.abcnews.com/images/US/teva-pharma-2-gty-ps-221103_1667481193658_hpMain_1x1_992.jpg)
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
![J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1571685528/teva1_1.jpg/teva1_1.jpg?VersionId=DZxWIUBep5WwbJo2nfwehxGzs6STVv3O)
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma
![Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals](https://images.moneycontrol.com/static-mcnews/2018/06/USFDAFDAPILLSDRUGSTABLETSPHARMA-770x433.jpg?impolicy=website&width=400&height=225)
Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals
![Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2018/01/stock-Teva-03-company.jpg)